People living with pulmonary fibrosis are still at risk from the COVID BA5 variant. While Paxlovid is a promising treatment, hear about possible interactions with other medications.
ILD and COVID
4 Ways to Lower Your Risk for COVID B1.5 if You Have ILD
Do those of us with pulmonary fibrosis still need to be concerned about COVID in 2022? COVID-19 B1.5 variant now predominant in North America and Europe and cases are rising, [Read More]
